Development of a new way to accurately measure human serum albumin (HSA) levels in people with chronic kidney disease has progressed in recent testing by Flinders University and Japanese researchers.

The World Health Organization reports that around the world, people acquire more than a million curable sexually transmitted infections (STIs) every day. Most of those STIs, however, are asymptomatic.

Droplet microfluidics allows for quicker point-of-care testing (POCT), but it is not always as accurate and currently requires an amount of external effort for proper handling. The Integrated Portable ...

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause ...

Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and ...

Functional drug screens on intact patient tumor samples are a promising approach to identify the best therapy for individual patients. The response of patient cancer tissue biopsies to drugs (or drug ...

Multiple respiratory viruses lead to high morbidity and mortality, yet global surveillance platforms focus primarily on seasonal influenza viruses. The COVID-19 pandemic and new RSV vaccines highlight ...

A research group in Japan has established a microfluidic control technology that can be applied to small blood testing devices and consequently developed a novel integrated immunoassay device. This ...

Since the end of 2019, the coronavirus disease (COVID-19) pandemic has wreaked havoc on public health and the global economy, with approximately 265 million confirmed cases and a death toll of more ...

Spike proteins: artist’s impression of the virus that causes COVID-19 (Courtesy: iStock/RomoloTavani) A rapid and low-cost test for the virus that causes COVID-19 has been developed by researchers in ...

A useful in vitro platform for drug discovery and development should predict response to treatment in a short period of time, be reliable and deliver results that have translational relevance.

Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Organs-on-Chips Market: Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global ...